Tony Mitchell joined COUR in 2023 as Vice President, Controller where he is responsible for all accounting and tax functions. Tony has over 20 years of experience in private and public accounting.
Before joining COUR, Tony served as Vice President, Controller at Jaguar Gene Therapy, LLC., where he oversaw the build out of the accounting function.
Prior to Jaguar, Tony held similar leadership roles at Melinta Therapeutics, Inc. and OFS Management, overseeing accounting, tax, and SEC reporting functions. Before this, Tony managed the global accounting and consolidations function at Hospira, Inc.
Tony began his career in public accounting at LJ Soldinger Associates, where he worked with a diverse client base ranging from mid-size public SEC engagements to development stage enterprises.
Tony holds a B.S. in Accounting from the University of Illinois Urbana-Champaign and is a certified public accountant. He received his MBA from the Kellogg School of Management at Northwestern University.